Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman鈥檚 uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.
Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
The global Intrauterine Contraceptive Devices (IUCD) market is projected to grow from US$ 3356.5 million in 2023 to US$ 3824.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.2% during the forecast period.
The US & Canada market for Intrauterine Contraceptive Devices (IUCD) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Intrauterine Contraceptive Devices (IUCD) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Intrauterine Contraceptive Devices (IUCD) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Intrauterine Contraceptive Devices (IUCD) include Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International and Melbea AG, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Intrauterine Contraceptive Devices (IUCD), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Intrauterine Contraceptive Devices (IUCD), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intrauterine Contraceptive Devices (IUCD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intrauterine Contraceptive Devices (IUCD) sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Intrauterine Contraceptive Devices (IUCD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Intrauterine Contraceptive Devices (IUCD) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International and Melbea AG, etc.
By Company
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
Segment by Type
Non-hormonal
Hormonal
Inert
Segment by Application
T Shapes
V Shapes
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intrauterine Contraceptive Devices (IUCD) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Intrauterine Contraceptive Devices (IUCD) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intrauterine Contraceptive Devices (IUCD) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Intrauterine Contraceptive Devices (IUCD) Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Non-hormonal
1.2.3 Hormonal
1.2.4 Inert
1.3 麻豆原创 by Application
1.3.1 Global Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 T Shapes
1.3.3 V Shapes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intrauterine Contraceptive Devices (IUCD) Sales Estimates and Forecasts 2018-2029
2.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region
2.2.1 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region (2018-2023)
2.2.3 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region (2024-2029)
2.2.4 Global Intrauterine Contraceptive Devices (IUCD) Revenue 麻豆原创 Share by Region (2018-2029)
2.3 Global Intrauterine Contraceptive Devices (IUCD) Sales Estimates and Forecasts 2018-2029
2.4 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region
2.4.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region (2018-2023)
2.4.3 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region (2024-2029)
2.4.4 Global Intrauterine Contraceptive Devices (IUCD) Sales 麻豆原创 Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Manufacturers
3.1.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Manufacturers (2018-2023)
3.1.2 Global Intrauterine Contraceptive Devices (IUCD) Sales 麻豆原创 Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intrauterine Contraceptive Devices (IUCD) in 2022
3.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Manufacturers
3.2.1 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Manufacturers (2018-2023)
3.2.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue 麻豆原创 Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Intrauterine Contraceptive Devices (IUCD) Revenue in 2022
3.3 Global Key Players of Intrauterine Contraceptive Devices (IUCD), Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Intrauterine Contraceptive Devices (IUCD) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Product Offered and Application
3.8 Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Type
4.1.1 Global Intrauterine Contraceptive Devices (IUCD) Historical Sales by Type (2018-2023)
4.1.2 Global Intrauterine Contraceptive Devices (IUCD) Forecasted Sales by Type (2024-2029)
4.1.3 Global Intrauterine Contraceptive Devices (IUCD) Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Type
4.2.1 Global Intrauterine Contraceptive Devices (IUCD) Historical Revenue by Type (2018-2023)
4.2.2 Global Intrauterine Contraceptive Devices (IUCD) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Intrauterine Contraceptive Devices (IUCD) Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Intrauterine Contraceptive Devices (IUCD) Price by Type
4.3.1 Global Intrauterine Contraceptive Devices (IUCD) Price by Type (2018-2023)
4.3.2 Global Intrauterine Contraceptive Devices (IUCD) Price Forecast by Type (2024-2029)
5 麻豆原创 Size by Application
5.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Application
5.1.1 Global Intrauterine Contraceptive Devices (IUCD) Historical Sales by Application (2018-2023)
5.1.2 Global Intrauterine Contraceptive Devices (IUCD) Forecasted Sales by Application (2024-2029)
5.1.3 Global Intrauterine Contraceptive Devices (IUCD) Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Application
5.2.1 Global Intrauterine Contraceptive Devices (IUCD) Historical Revenue by Application (2018-2023)
5.2.2 Global Intrauterine Contraceptive Devices (IUCD) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Intrauterine Contraceptive Devices (IUCD) Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Intrauterine Contraceptive Devices (IUCD) Price by Application
5.3.1 Global Intrauterine Contraceptive Devices (IUCD) Price by Application (2018-2023)
5.3.2 Global Intrauterine Contraceptive Devices (IUCD) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Type
6.1.1 US & Canada Intrauterine Contraceptive Devices (IUCD) Sales by Type (2018-2029)
6.1.2 US & Canada Intrauterine Contraceptive Devices (IUCD) Revenue by Type (2018-2029)
6.2 US & Canada Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Application
6.2.1 US & Canada Intrauterine Contraceptive Devices (IUCD) Sales by Application (2018-2029)
6.2.2 US & Canada Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2018-2029)
6.3 US & Canada Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Country
6.3.1 US & Canada Intrauterine Contraceptive Devices (IUCD) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Intrauterine Contraceptive Devices (IUCD) Sales by Country (2018-2029)
6.3.3 US & Canada Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Type
7.1.1 Europe Intrauterine Contraceptive Devices (IUCD) Sales by Type (2018-2029)
7.1.2 Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Type (2018-2029)
7.2 Europe Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Application
7.2.1 Europe Intrauterine Contraceptive Devices (IUCD) Sales by Application (2018-2029)
7.2.2 Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2018-2029)
7.3 Europe Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Country
7.3.1 Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Intrauterine Contraceptive Devices (IUCD) Sales by Country (2018-2029)
7.3.3 Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size
8.1.1 China Intrauterine Contraceptive Devices (IUCD) Sales (2018-2029)
8.1.2 China Intrauterine Contraceptive Devices (IUCD) Revenue (2018-2029)
8.2 China Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Application
8.2.1 China Intrauterine Contraceptive Devices (IUCD) Sales by Application (2018-2029)
8.2.2 China Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Type
9.1.1 Asia Intrauterine Contraceptive Devices (IUCD) Sales by Type (2018-2029)
9.1.2 Asia Intrauterine Contraceptive Devices (IUCD) Revenue by Type (2018-2029)
9.2 Asia Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Application
9.2.1 Asia Intrauterine Contraceptive Devices (IUCD) Sales by Application (2018-2029)
9.2.2 Asia Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2018-2029)
9.3 Asia Intrauterine Contraceptive Devices (IUCD) Sales by Region
9.3.1 Asia Intrauterine Contraceptive Devices (IUCD) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Intrauterine Contraceptive Devices (IUCD) Revenue by Region (2018-2029)
9.3.3 Asia Intrauterine Contraceptive Devices (IUCD) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Sales by Country
10.3.1 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Intrauterine Contraceptive Devices (IUCD) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer Healthcare AG
11.1.1 Bayer Healthcare AG Company Information
11.1.2 Bayer Healthcare AG Overview
11.1.3 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare AG Recent Developments
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Teva Pharmaceutical Industries Ltd Company Information
11.2.2 Teva Pharmaceutical Industries Ltd Overview
11.2.3 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.3 Actavis PLC
11.3.1 Actavis PLC Company Information
11.3.2 Actavis PLC Overview
11.3.3 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Actavis PLC Recent Developments
11.4 Medicines360
11.4.1 Medicines360 Company Information
11.4.2 Medicines360 Overview
11.4.3 Medicines360 Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Medicines360 Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medicines360 Recent Developments
11.5 Trimedic Supply Network Ltd
11.5.1 Trimedic Supply Network Ltd Company Information
11.5.2 Trimedic Supply Network Ltd Overview
11.5.3 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Trimedic Supply Network Ltd Recent Developments
11.6 Medisafe Distribution Inc
11.6.1 Medisafe Distribution Inc Company Information
11.6.2 Medisafe Distribution Inc Overview
11.6.3 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Medisafe Distribution Inc Recent Developments
11.7 Pace Pharmaceuticals Inc
11.7.1 Pace Pharmaceuticals Inc Company Information
11.7.2 Pace Pharmaceuticals Inc Overview
11.7.3 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pace Pharmaceuticals Inc Recent Developments
11.8 DKT International
11.8.1 DKT International Company Information
11.8.2 DKT International Overview
11.8.3 DKT International Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 DKT International Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 DKT International Recent Developments
11.9 Melbea AG
11.9.1 Melbea AG Company Information
11.9.2 Melbea AG Overview
11.9.3 Melbea AG Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Melbea AG Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Melbea AG Recent Developments
11.10 Pregna International Limited
11.10.1 Pregna International Limited Company Information
11.10.2 Pregna International Limited Overview
11.10.3 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pregna International Limited Recent Developments
11.11 Ocon Medical Ltd
11.11.1 Ocon Medical Ltd Company Information
11.11.2 Ocon Medical Ltd Overview
11.11.3 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ocon Medical Ltd Recent Developments
11.12 SMB Corporation
11.12.1 SMB Corporation Company Information
11.12.2 SMB Corporation Overview
11.12.3 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 SMB Corporation Recent Developments
11.13 Mona Lisa N.V
11.13.1 Mona Lisa N.V Company Information
11.13.2 Mona Lisa N.V Overview
11.13.3 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Mona Lisa N.V Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intrauterine Contraceptive Devices (IUCD) Industry Chain Analysis
12.2 Intrauterine Contraceptive Devices (IUCD) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intrauterine Contraceptive Devices (IUCD) Production Mode & Process
12.4 Intrauterine Contraceptive Devices (IUCD) Sales and 麻豆原创ing
12.4.1 Intrauterine Contraceptive Devices (IUCD) Sales Channels
12.4.2 Intrauterine Contraceptive Devices (IUCD) Distributors
12.5 Intrauterine Contraceptive Devices (IUCD) Customers
13 麻豆原创 Dynamics
13.1 Intrauterine Contraceptive Devices (IUCD) Industry Trends
13.2 Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Drivers
13.3 Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Challenges
13.4 Intrauterine Contraceptive Devices (IUCD) 麻豆原创 Restraints
14 Key Findings in The Global Intrauterine Contraceptive Devices (IUCD) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
听
听
*If Applicable.
